StockLearn from Clustermicro · Stock Breakout ScannerStockLearn
← US stocks and world indices

Bristol Myers Squibb (BMY)

US-listed stock · Healthcare · Pharmaceuticals · close 17 Nov 2026
Close
$61.35
Day change
-2.5%
1 month
+2.7%
6 months
+7.6%
1 year
+31.1%
3 years
+20.7%
5 years
+3.2%
From 52-week high
-9.9%
Weinstein stage
Stage 2
advancing
Bristol Myers Squibb closed at $61.35 on 17 Nov 2026. Over the past year it has gained 31.1%, and over five years +3% in all (+0.6% a year). It is 9.9% below its 52-week closing high of $68.09, set on 3 Sep 2026, and 34.0% above its 52-week closing low of $45.79. The price is above its 200-day average of $60.41 - an average that is itself still rising. On Stan Weinstein's stage analysis it is in Stage 2: advancing - above a rising 150-day average. Its deepest fall from a peak in the period shown was 51%. At that price it trades at 13.6 times its last twelve months' earnings ($4.50 a share, to 30 Sep 2026); net income changed +53% on a year earlier. On revenue of $50.0B (+4.2% on a year earlier), the net margin was 18.5%.

Valuation and profitability

Market value
$126.0B
P/E (TTM)
13.6
Price / book
5.4
Net margin
18.5%
Return on equity
39.5%
Revenue growth
+4.2%
Net income growth
+53%

From the company's SEC filings: the last twelve months to 30 Sep 2026, built from its 10-K and 10-Q reports. P/E and market value use the 17 Nov 2026 close, with the latest quarter's diluted share count; P/E is market value over net income, which stays right through a stock split. Growth compares with the twelve months a year earlier.

Price, RSI and MACD

Price · +4.8% over the period
5357616569May 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26
RSI (14) · 47.0
305070
MACD (12, 26, 9) · histogram -0.01
-1.9-0.90.21.32.4
Price · +31.1% over the period
4451576369Nov 25Jan 26Mar 26May 26Jul 26Sep 26Nov 26
RSI (14) · 47.0
305070
MACD (12, 26, 9) · histogram -0.01
-1.9-0.90.21.32.4
Price · +5.0% over the period
4148556269Nov 24Mar 25Jul 25Nov 25Mar 26Jul 26Nov 26
RSI (14) · 47.0
305070
MACD (12, 26, 9) · histogram -0.01
-3.1-1.7-0.412.4
Price · +22.3% over the period
3846546270Nov 23Apr 24Sep 24Feb 25Jul 25Dec 25May 26Oct 26
RSI (14) · 47.0
305070
MACD (12, 26, 9) · histogram -0.01
-3.1-1.7-0.31.12.5
Price · +3.3% over the period
3849607183Aug 22May 23Feb 24Nov 24Aug 25May 26
RSI (14) · 47.0
305070
MACD (12, 26, 9) · histogram -0.01
-3.1-1.7-0.21.22.6
Price: daily close adjusted for stock splits, dashed line the 150-day moving average. MACD: green line, orange dashed signal, bars the histogram. Longer periods are drawn from every second or third session.

50-day average $61.75 · 200-day average $60.41 · 52-week closing range $45.79 – $68.09

Other Healthcare stocks

NameClose1M1Y5YP/EStage
Merck$143.37-1.8%+54.4%+73.6%144.82
Johnson & Johnson$278.70+9.1%+39.6%+70.7%42.42
Eli Lilly$1,415.55+12.6%+38.5%+442.0%45.92
Gilead Sciences$170.26+9.0%+37.2%+152.4%loss2
Regeneron Pharmaceuticals$957.76+21.1%+36.0%+49.2%21.02
Amgen$457.93+5.9%+34.0%+122.5%26.62
Elevance Health$433.93+1.3%+31.1%+1.0%18.42
McKesson$1,091.67+8.6%+27.6%+387.7%27.12
AbbVie$292.82+2.6%+25.1%+149.5%50.22
Vertex Pharmaceuticals$534.20+6.9%+23.1%+183.8%34.32
UnitedHealth$389.68-2.9%+21.6%-13.2%22.12
Thermo Fisher$686.79-0.5%+21.1%+7.8%36.02
Pfizer$28.47-3.8%+13.5%-44.0%40.62
CVS Health$85.81-7.1%+9.4%-7.5%10.03
Medtronic$102.32+8.0%+6.3%-13.2%25.12
HCA Healthcare$501.19+9.2%+5.0%+105.5%16.11
Danaher Corporation$225.77-1.4%+2.4%-17.8%36.82
Stryker Corporation$317.54+7.8%-11.8%+21.2%33.71
Abbott Laboratories$104.71-0.2%-19.5%-18.6%38.72
Intuitive Surgical$430.53+0.9%-21.3%+19.1%51.21

← All US stocks and world indices · NSE stocks

Daily closes to 17 Nov 2026, adjusted for stock splits (not dividends), from Google Finance and Yahoo Finance. US stock prices in US dollars; index levels in points. Figures may be delayed and are for information only.
For research & education only — not investment advice or a recommendation to buy or sell any security. StockLearn is an independent product of ClusterMicro Technologies, not affiliated with or endorsed by any exchange or index provider. ClusterMicro Technologies is not a SEBI-registered investment adviser. Consult a SEBI-registered adviser before investing.